Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial
Elizabeth S. McDonald, Justin Romanoff, Habib Rahbar et al. · Radiology · 2020
Background The Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Cancer Research Group A6702 multicenter trial helped confirm the potential of diffusion-weighted MRI for improving differential diagnosis of suspicious breast abnormalities and reducing unnecessary biopsies. A prespecified secondary objective was to explore the relative value of different approaches for quantitative assessment of lesions at diffusion-weighted MRI. Purpose To determine whether alternate calculations of apparent diffusion coefficient (ADC) can help further improve diagnostic performance versus mean ADC values alone for analysis of suspicious breast lesions at MRI. Materials and Methods This prospective trial (ClinicalTrials.gov identifier: NCT02022579) enrolled consecutive women (from March 2014 to April 2015) with a Breast Imaging Reporting and Data System category of 3, 4, or 5 at breast MRI. All study participants underwent standardized diffusion-weighted MRI (b = 0, 100, 600, and 800 sec/mm2). Centralized ADC measures were performed, including manually drawn whole-lesion and hotspot regions of interest, histogram metrics, normalized ADC, and variable b-value combinations. Diagnostic performance was estimated by using the area under the receiver operating characteristic curve (AUC). Reduction in biopsy rate (maintaining 100% sensitivity) was estimated according to thresholds for each ADC metric. Results Among 107 enrolled women, 81 lesions with outcomes (28 malignant and 53 benign) in 67 women (median age, 49 years; interquartile range, 41–60 years) were analyzed. Among ADC metrics tested, none improved diagnostic performance versus standard mean ADC (AUC, 0.59–0.79 vs AUC, 0.75; P = .02–.84), and maximum ADC had worse performance (AUC, 0.52; P < .001). The 25th-percentile ADC metric provided the best performance (AUC, 0.79; 95% CI: 0.70, 0.88), and a threshold using median ADC provided the greatest reduction in biopsy rate of 23.9% (95% CI: 14.8, 32.9; 16 of 67 BI-RADS category 4 and 5 lesions). Nonzero minimum b value (100, 600, and 800 sec/mm2) did not improve the AUC (0.74; P = .28), and several combinations of two b values (0 and 600, 100 and 600, 0 and 800, and 100 and 800 sec/mm2; AUC, 0.73–0.76) provided results similar to those seen with calculations of four b values (AUC, 0.75; P = .17–.87). Conclusion Mean apparent diffusion coefficient calculated with a two–b-value acquisition is a simple and sufficient diffusion-weighted MRI metric to augment diagnostic performance of breast MRI compared with more complex approaches to apparent diffusion coefficient measurement. © RSNA, 2020 Online supplemental material is available for this article.
Cited by 43 works. doi:10.1148/radiol.2020202465
Authors
- Elizabeth S. McDonald
- Justin Romanoff
- Habib Rahbar
- Averi E. Kitsch
- Sara M. Harvey
- Jennifer G. Whisenant
- Thomas E. Yankeelov
- Linda P. Moy
- Wendy B. DeMartini
- Başak E. Doğan
- Wei Tse Yang
- Lilian C. Wang
- Bonnie N. Joe
- Lisa J. Wilmes
- Nola M. Hylton
- Karen Y. Oh
- Luminita A. Tudorica
- Colleen H. Neal
- Dariya I. Malyarenko
- Christopher Comstock
References
- Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging
- Breast MRI: State of the Art
- Supplemental MRI Screening for Women with Extremely Dense Breast Tissue
- ADC Mapping of Benign and Malignant Breast Tumors
- Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force
- Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates
- Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer
- Bootstrap estimation of diagnostic accuracy with patient-clustered data
- Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion
- Diffusion-weighted MR for Differentiation of Breast Lesions at 3.0 T: How Does Selection of Diffusion Protocols Affect Diagnosis?